Detalhe da pesquisa
1.
Phosphoproteomic Analysis of Platelets in Severe Obesity Uncovers Platelet Reactivity and Signaling Pathways Alterations.
Arterioscler Thromb Vasc Biol
; 41(1): 478-490, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33147989
2.
Platelet Lipidome Fingerprint: New Assistance to Characterize Platelet Dysfunction in Obesity.
Int J Mol Sci
; 23(15)2022 Jul 28.
Artigo
Inglês
| MEDLINE | ID: mdl-35955459
3.
Weight loss normalizes enhanced expression of the oncogene survivin in visceral adipose tissue and blood leukocytes from individuals with obesity.
Int J Obes (Lond)
; 45(1): 206-216, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32546857
4.
Naturally presented HLA class I-restricted epitopes from the neurotrophic factor S100-ß are targets of the autoimmune response in type 1 diabetes.
FASEB J
; 33(5): 6390-6401, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30817223
5.
A Combination of Proteomic Approaches Identifies A Panel of Circulating Extracellular Vesicle Proteins Related to the Risk of Suffering Cardiovascular Disease in Obese Patients.
Proteomics
; 19(1-2): e1800248, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30536591
6.
GPVI surface expression and signalling pathway activation are increased in platelets from obese patients: Elucidating potential anti-atherothrombotic targets in obesity.
Atherosclerosis
; 281: 62-70, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30658193
7.
Data on hyper-activation of GPVI signalling in obese patients: Towards the identification of novel antiplatelet targets in obesity.
Data Brief
; 23: 103784, 2019 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-31372431
8.
High variability in CYP21A2 mutated alleles in Spanish 21-hydroxylase deficiency patients, six novel mutations and a founder effect.
Clin Endocrinol (Oxf)
; 64(3): 330-6, 2006 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-16487445